Medical treatment for urogenital tuberculosis (UGTB)

Medical treatment for urogenital tuberculosis (UGTB)

Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney...

Full description

Bibliographic Details
Main Author: Wejse, Christian
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2018-08-01
Series:GMS Infectious Diseases
Online Access:http://www.egms.de/static/en/journals/id/2018-6/id000039.shtml
id doaj-4222ed197cbb4fea85589f3cb312a102
record_format Article
spelling doaj-4222ed197cbb4fea85589f3cb312a1022020-11-25T03:31:04ZengGerman Medical Science GMS Publishing HouseGMS Infectious Diseases2195-88312018-08-016Doc0410.3205/id000039Medical treatment for urogenital tuberculosis (UGTB)Wejse, Christian0Department of Infectious Diseases/Center for Global Health, Dept of Public Health, Aarhus University, DenmarkUrogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18–24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.http://www.egms.de/static/en/journals/id/2018-6/id000039.shtml
collection DOAJ
language English
format Article
sources DOAJ
author Wejse, Christian
spellingShingle Wejse, Christian
Medical treatment for urogenital tuberculosis (UGTB)
GMS Infectious Diseases
author_facet Wejse, Christian
author_sort Wejse, Christian
title Medical treatment for urogenital tuberculosis (UGTB)
title_short Medical treatment for urogenital tuberculosis (UGTB)
title_full Medical treatment for urogenital tuberculosis (UGTB)
title_fullStr Medical treatment for urogenital tuberculosis (UGTB)
title_full_unstemmed Medical treatment for urogenital tuberculosis (UGTB)
title_sort medical treatment for urogenital tuberculosis (ugtb)
publisher German Medical Science GMS Publishing House
series GMS Infectious Diseases
issn 2195-8831
publishDate 2018-08-01
description Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18–24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.
url http://www.egms.de/static/en/journals/id/2018-6/id000039.shtml
work_keys_str_mv AT wejsechristian medicaltreatmentforurogenitaltuberculosisugtb
_version_ 1724573850107117568

Similar Items